|Description||cardiology device manufacturer|
|Series B, 4/07 |
Scottish Equity Partners
Heartscape Technologies, Inc. is a privately held venture funded company engaged in the development and marketing of the PRIME ECGÂ® System (PRIME), a breakthrough medical device that is designed to allow more accurate and rapid diagnosis of heart attacks (acute myocardial infarction or AMI) and ischemia. PRIME is a patented, FDA approved product with an annual US market opportunity of approximately $1 billion.